Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0613320060120010001
Journal of the Korean Bone and Joint Tumor Soceity
2006 Volume.12 No. 1 p.1 ~ p.8
Clinical Outcome of Stage IIB Osteosarcomas in Long Bones
Chung Yang-Guk

Rhee Seung-Koo
Kim Hyoung-Min
Park Won-Jong
Lee An-Hi
Park Jeong-Mi
Kang Yong-Koo
Choi Kwang-Cheon
Abstract
Purpose: To analyze the clinical outcome of stage IIB osteosarcomas arisen in the long bones.

Materials and Methods: Since February 1993, 58 Enneking stage IIB osteosarcomas arisen in long bones were managed and followed at least one year at our four university hospitals. There were 48 wide resections, 2 marginal resections and 8 amputations. The mean follow up period was 4.1years (up to 12.2years). Local recurrence, distant metastasis, complication, survival rate, and oncologic and functional results were evaluated.

Results: At the last follow up, 35 patients were CDF, 9 were NED, 5 were AWD, 7 were DOD and the remained 2 died with unrelated disease. Eight local recurrences (13.8%) and 18 distant metastases (31.0%) were occurred. Nine infections were developed after 48 reconstructions (18.8%). Overall functional outcome was 24.3 (81.%). The 5 year overall survival rate was 84.6% and the continuous disease-free survival rate was 68.7% at 5 years and 42.3% at 10 years.

Conclusion: Forty-six of 58 stage IIB osteosarcomas arisen in long bones (79.3%) showed CDF or NED at an average 4.1 year follow up. Overall 5-year survival rate was 84.6% and overall functional outcome score was 24.3, which were comparable to those of other studies.
KEYWORD
Long bone, Osteosarcoma, Stage IIB, Clinical outcome
FullTexts / Linksout information
 
Listed journal information
´ëÇÑÀÇÇÐȸ ȸ¿ø